期刊
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
卷 121, 期 5, 页码 1003-1007出版社
ELSEVIER TAIWAN
DOI: 10.1016/j.jfma.2021.12.028
关键词
COVID-19; mRNA vaccine; Pityriasis rosea
In this case report, cutaneous PR-like eruptions following COVID-19 mRNA-1273 vaccination are described. During the COVID-19 pandemic, PR or PR-like eruptions related to COVID-19 infection or vaccination have been rarely reported.
Pityriasis rosea (PR) is a self-limited disease with exanthematous papulosquamous rashes mostly associated with reactivation of human herpesvirus (HHV)-6 or HHV-7. PR-like eruptions, which occur along with peripheral eosinophilia, interface dermatitis, and eosinophils on histopathology, may result from medications or vaccinations. Previously, PR-like eruptions had been noted following vaccination for influenza or other vaccines. During this pandemic, acute COVID-19 infection has been related to PR or PR-like eruptions in several cases. Various COVID-19 vaccines associated with PR-like eruptions were rarely reported. Herein, we report a case of cutaneous PR-like eruptions following COVID-19 mRNA-1273 vaccination. Copyright (c) 2022, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据